Status:

COMPLETED

A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients

Lead Sponsor:

Indiana University School of Medicine

Collaborating Sponsors:

Pfizer

University of Pennsylvania

Conditions:

Panic Disorder

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The primary objective for the study is to test the hypothesis that sertraline plus alprazolam XR will result in superior early stabilization of primary care PD patients versus sertraline/placebo over ...

Eligibility Criteria

Inclusion

  • Subjects will include men and women over the age of eighteen;
  • the ability to give written informed consent;
  • current principal or co-principal psychiatric diagnosis of panic disorder with or without agoraphobia based on DSM-IV criteria (American Psychiatric Association, 1994);
  • willing to use an effective means of contraception;
  • free of psychoactive medications for at least 2 weeks prior to study enrollment;
  • not actively be suicidal.

Exclusion

  • actively suicidal;
  • medical conditions for which either sertraline or alprazolam XR would be contraindicated;
  • recent six month history of substance or alcohol abuse;
  • history or presence of psychotic or bipolar disorder;
  • women who are pregnant or breastfeeding;
  • history or presence of a seizure disorder or a known history of more than one childhood febrile seizure;
  • presence of a personality disorder severe enough to compromise the investigator's ability to evaluate the efficacy and safety of the study medication;
  • concomitant therapy with other psychotropic medication(s);
  • clinically significant abnormality during physical examination, vital signs, EKG, urine drug screen, or laboratory tests at the screen visit.

Key Trial Info

Start Date :

December 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2007

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00198094

Start Date

December 1 2003

End Date

September 1 2007

Last Update

October 22 2007

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

University of South Florida, Department of Psychiatry and Behavioral Medicine

Tampa, Florida, United States, 33613

2

University Hospital Outpatient Center, Psychiatry

Indianapolis, Indiana, United States, 46202

3

University of Pennsylvania, Mood and Anxiety Disorders Section

Philadelphia, Pennsylvania, United States, 19104-3309